NCT01464398

Brief Summary

The purpose of this study is to determine the effects of stress reduction on glucose, blood pressure, quality of life and overall health and well-being in overweight or obese women, either with Polycystic Ovary Syndrome (PCOS) or without PCOS (non-PCOS). Stress reduction treatment sessions will include one or more of the following activities: breathing exercises, meditation, stretching exercises or health education activities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2011

Completed
1 day until next milestone

Study Start

First participant enrolled

November 1, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 3, 2011

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

May 14, 2015

Status Verified

May 1, 2015

Enrollment Period

2.6 years

First QC Date

October 31, 2011

Last Update Submit

May 13, 2015

Conditions

Keywords

Polycystic Ovary Syndromestressmindfulnessmeditationhealth educationwomenoverweightobesity

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Toronto Mindfulness Scale at 8 weeks

    baseline and 8 weeks

Secondary Outcomes (9)

  • Change from Baseline in Toronto Mindfulness Scale at 16 weeks

    baseline and 16 weeks

  • Change from Baseline in Hemoglobin A1c at 8 weeks

    baseline and 8 weeks

  • Change from Baseline in Hemoglobin A1c at 16 weeks

    baseline and 16 weeks

  • Change from Baseline in Mean Arterial Pressure at 8 weeks

    baseline and 8 weeks

  • Change from Baseline in Mean Arterial Pressure at 16 weeks

    baseline and 16 weeks

  • +4 more secondary outcomes

Study Arms (2)

Stress reduction

ACTIVE COMPARATOR

Mindfulness-based stress reduction

Behavioral: Stress reduction

Stress reduction with Health education

ACTIVE COMPARATOR

General stress management and health education

Behavioral: Stress reduction with Health education

Interventions

8 weekly sessions

Stress reduction

8 weekly sessions

Stress reduction with Health education

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women, age 18 years or older
  • Body mass index (BMI) ≥ 25 kg/m2 (overweight or obese)

You may not qualify if:

  • Current pregnancy
  • Secondary causes of hyperandrogenemia, such as known or suspected androgen secreting tumors, Cushing's syndrome, or hyperprolactinemia (prolactin \>30)
  • Untreated hypothyroidism or hyperthyroidism (defined as TSH \<0.2 or \>5.5 mIU/mL)
  • Severe active neuropsychological disorder such as psychosis or suicidal ideation
  • Severe untreated depression or anxiety. Women with severe depression or anxiety will be allowed to participate if they are under the care of a mental health specialist as long as they have permission to do so from their mental health specialist and will continue to follow-up with their mental health specialist during the study.
  • History of an inpatient admission for psychiatric disorder within the past two years
  • Active alcohol or drug abuse
  • Inability to read, speak or write English
  • Inability to commit to the intervention and follow-up
  • Current enrollment in a stress reduction program
  • Mindfulness practice within the past 6 months (regular formal practice at least once a week)
  • Current enrollment in other investigative studies
  • Type 1 diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State College of Medicine, Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Location

Related Publications (2)

  • Raja-Khan N, Agito K, Shah J, Stetter CM, Gustafson TS, Socolow H, Kunselman AR, Reibel DK, Legro RS. Mindfulness-Based Stress Reduction in Women with Overweight or Obesity: A Randomized Clinical Trial. Obesity (Silver Spring). 2017 Aug;25(8):1349-1359. doi: 10.1002/oby.21910. Epub 2017 Jul 7.

  • Raja-Khan N, Agito K, Shah J, Stetter CM, Gustafson TS, Socolow H, Kunselman AR, Reibel DK, Legro RS. Mindfulness-based stress reduction for overweight/obese women with and without polycystic ovary syndrome: design and methods of a pilot randomized controlled trial. Contemp Clin Trials. 2015 Mar;41:287-97. doi: 10.1016/j.cct.2015.01.021. Epub 2015 Feb 7.

MeSH Terms

Conditions

Polycystic Ovary SyndromeOverweightObesityStress, PsychologicalHealth Education

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System DiseasesOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Nazia Raja-Khan, MD

    Pennsylvania State University College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., Assistant Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism

Study Record Dates

First Submitted

October 31, 2011

First Posted

November 3, 2011

Study Start

November 1, 2011

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

May 14, 2015

Record last verified: 2015-05

Locations